Cochlear grows, but not the same as before Covid
Cochlear may have grown its sales from the depths of a Covid-19 slump in sales and surgeries to reach a new record level in FY 22, but the company has not returned to what it was before the pandemic. The maker of Cochlear implants reported sales revenue grew 10 per cent in the year to…